These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23550858)

  • 1. Is there a nuchal translucency threshold above which biochemistry is unnecessary for 1st trimester screening in the Chinese population?
    Liao C; Li DZ
    J Obstet Gynaecol; 2013 Apr; 33(3):280-1. PubMed ID: 23550858
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Down syndrome screening performance using first-trimester serum markers.
    Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland.
    Peuhkurinen S; Laitinen P; Honkasalo T; Ryynanen M; Marttala J
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):769-74. PubMed ID: 23369035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingent screening for Down syndrome completed in the first trimester: a multicenter study.
    Muñoz-Cortes M; Arigita M; Falguera G; Seres A; Guix D; Baldrich E; Acera A; Torrent A; Rodriguez-Veret A; Lopez-Quesada E; Garcia-Moreno R; Gonce A; Borobio V; Borrell A
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):396-400. PubMed ID: 21674658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required.
    Vadiveloo T; Crossley JA; Aitken DA
    Prenat Diagn; 2009 Jan; 29(1):79-82. PubMed ID: 19097036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester.
    Madsen HN; Ball S; Wright D; Tørring N; Petersen OB; Nicolaides KH; Spencer K
    Ultrasound Obstet Gynecol; 2011 Jan; 37(1):38-47. PubMed ID: 20878678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing.
    Kagan KO; Staboulidou I; Cruz J; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):542-7. PubMed ID: 20503223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of a first-trimester Down syndrome screening concept on a mix of 11,107 high- and low-risk patients at a private center for prenatal medicine in Germany.
    Schaelike M; Kossakiewicz M; Kossakiewicz A; Schild RL
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):140-5. PubMed ID: 19362411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry.
    Hadlow NC; Hewitt BG; Dickinson JE; Jacoby P; Bower C
    BJOG; 2005 Nov; 112(11):1561-4. PubMed ID: 16225579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester risk assessment for trisomies 21 and 18 in twin pregnancy.
    Chasen ST; Perni SC; Kalish RB; Chervenak FA
    Am J Obstet Gynecol; 2007 Oct; 197(4):374.e1-3. PubMed ID: 17904965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.